MoneyWorks4Me

Aarti Drugs informs about loss of share certificate

14 Jun 2022 Evaluate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, Aarti Drugs has informed that the Company has issued the Letter of Confirmation in lieu of Duplicate Share Certificate.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1785.50
Dr. Reddys Labs. 1196.70
Cipla 1322.75
Lupin 2020.40
Zydus Lifesciences 1136.60
View more..